MedTrace Logo

Efficacy and Safety of Sirolimus in Combination With Tacrolimus

NCT00141804 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 190

Last updated 2005-12-01

No results posted yet for this study

Summary

To study the efficacy and safety of the administration of Tacrolimus in combination with Sirolimus for the prevention of acute rejection in patients after renal transplantation

Conditions

  • Kidney Transplantation

Interventions

DRUG

Sirolimus

Sponsors & Collaborators

  • Proverum GmbH

    collaborator UNKNOWN

  • KKS Netzwerk

    collaborator NETWORK

  • Fujisawa GmbH

    collaborator INDUSTRY

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Heiner H. Wolters, Dr. med. · University Hospital Muenster

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Completion
2005-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00141804 on ClinicalTrials.gov